Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Radiation Therapy
  •  Radiation Oncology
  •  Brain and Spinal Cord Cancer
  •  Immunology
  •  Endometrial Cancer
  •  Lung Cancers
  •  Haemato-Oncology
  •  Chemotherapy and Radiotherapy

Abstract

Citation: Clin Oncol. 2017;2(1):1190.DOI: 10.25107/2474-1663.1190

Risk Factors for Clostridium Difficile Colitis in Patients Undergoing Treatment for Gynecologic Cancer

Blake EA, Sheeder J, Carrubba A, Okland T, Doo D and Guntupalli S


Department of Obstetrics and Gynecology, University of Colorado, USA
Department of Obstetrics and Gynecology, University of Colorado School of Medicine, USA

*Correspondance to: Blake EA 

 PDF  Full Text Research Article | Open Access

Abstract:

Objectives: Clostridium Difficile Associated Diarrhea (CDAD) is a common potentially dangerous complication of treatment for gynecologic cancers and is an important metric for quality of hospital care. We evaluated risk factors associated with CDAD in gynecologic oncology patients.
Design: Retrospective chart review Setting: Inpatient gynecologic oncology ward Patients: Women with histological confirmation of a gynecologic malignancy admitted for >24 hours were abstracted at a tertiary referral center over four years. Both surgical and medical admissions included.
Methods: Details regarding health status and treatments were abstracted. Diagnosis of CDAD was made witha positive PCR result. Standard statistical tests were used.
Results: A total of 728 women were included. Fifteen patients had positive PCR proven CDAD (2.01%). In bivariate analysis, cephalosporin exposure (OR 0.21, 95% CI 0.06-0.74) and surgical admission (OR 0.28, 95% CI 0.09- 0.87) were associated with decreased risk of CDAD. Platinum based chemotherapy use (OR 3.61, 95% CI 1.29-10.13), radiation therapy (OR 6.82, 95% CI 1.81- 25.7), and early stage (OR 3.59, 95% CI 1.26-10.21) were associated with increased risk of CDAD. In logistic regression analysis, chemotherapy use (aOR 5.7, 95% CI 1.91-17.10) and early stage disease (aOR 5.7, 95% CI 1.22-11.05), were found to be independent predictors of CDAD. Cephalosporin use was independently found to be associated with decreased risk of CDAD (aOR 0.20, 95% CI 0.05-0.75). Conclusions: Platinum based chemotherapies and early stage disease are significant risk factors for the development of CDAD in gynecologic oncology patients. Attention to these risk factors is warranted to prevent the dangerous sequelae of infection with this organism.

Keywords:

Cite the Article:

Blake EA, Sheeder J, Carrubba A, Okland T, Doo D, Guntupalli S. Risk Factors for Clostridium Difficile Colitis in Patients Undergoing Treatment for Gynecologic Cancer. Clin Oncol. 2017; 2: 1190.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Molecular Pathological Signatures of Gastric Cancer in Koreans Revealed by Label-Free Proteomics
 Abstract  PDF  Full Text
Is There Re-Staging Surgery Necessity for Women with Borderline Ovarian Tumors
 Abstract  PDF  Full Text
View More...